Skip Navigation



BJA Advance Access published online on March 10, 2006

British Journal of Anaesthesia, doi:10.1093/bja/ael046
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
96/5/597    most recent
ael046v1
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Sou, J.-H.
Right arrow Articles by Chen, H.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sou, J.-H.
Right arrow Articles by Chen, H.-H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Board of Management and Trustees of the British Journal of Anaesthesia 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Accepted January 6, 2006

Laboratory Investigation

Ketamine, but not propofol, anaesthesia is regulated by metabotropic glutamate 5 receptors

J.-H. Sou 1, M.-H. Chan 2, and H.-H. Chen 2 *

1 Institute of Pharmacology and Toxicology, Tzu Chi University, Hualien, Taiwan, R.O.C.; Department of Health, Yuli Hospital, Executive Yuan, Hualien, Taiwan, R.O.C.
2 Institute of Pharmacology and Toxicology, Tzu Chi University, Hualien, Taiwan, R.O.C.

* To whom correspondence should be addressed.
H.-H. Chen, E-mail: hwei{at}mail.tcu.edu.tw


   Abstract

Background. Group I metabotropic glutamate receptors (mGluRs) have been reported to regulate N-methyl-D-aspartate (NMDA) receptor function in various brain regions. The selective mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) can potentiate NMDA antagonists such as PCP and MK-801-induced behavioural responses. In the present study, the role of group I mGluRs on ketamine- and propofol-induced general anaesthesia was examined.

Methods. Mice were pretreated with various doses of the group I mGluR agonist (S)-3,5-dihydroxyphenylglycine (DHPG), selective mGluR5 agonist (RS)-2-chloro-5-hydroxyphenylglycine (CHPG), mGluR1 antagonist 7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxylate ethyl ester (CPCCOEt) and mGluR5 antagonist MPEP followed by administration of ketamine (120 mg kg-1) or propofol (140 mg kg-1) to induce anaesthesia. The duration of loss of righting reflex was recorded.

Results. DHPG and CHPG antagonized and MPEP potentiated ketamine-induced anaesthesia in a dose-dependent manner. CPCCOEt was in effective. However, propofol-induced anaesthesia was not affected after manipulating mGluR1 and mGluR5 receptors.

Conclusions. mGluR5 receptors play an important role in modulation of anaesthesia induced by ketamine, but not propofol.

Keywords: anaesthesia; anaesthetics i.v., ketamine; anaesthetics i.v., propofol; receptors; mGluR1; receptors, mGluR5.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Br J AnaesthHome page
M. Smith and R. P. Mahajan
Clinical neuroscience: relevance to current practice
Br. J. Anaesth., July 1, 2007; 99(1): 1 - 3.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.